|
2020 |
DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache. |
Kelly L Karlage, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2019 |
Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions. |
Christopher Cartmell |
|
2019 |
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation. |
Fei Yin, Ph.D. |
|
2019 |
Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light. |
Mohab M. Ibrahim, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2019 |
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. |
Tally Largent-Milnes, PhD, Kathleen Rodgers, Ph.D., Todd Vanderah, PhD |
|
2019 |
Animal Models for the Study of Bone-Derived Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
Cellular Specificity and Inter-cellular Coordination in the Brain Bioenergetic System: Implications for Aging and Neurodegeneration. |
Fei Yin, Ph.D. |
|
2019 |
Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
|
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. |
Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2017 |
Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. |
|
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Synthetic analogues of cyanobacterial alkaloid cylindrospermopsin and their toxicological activity. |
Christopher Cartmell |
|
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. |
Nam Lee, Ph.D. |
|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD, FAAPS |
